68ga-nota-sna002
Positron-Emission Tomography(PET)
SmartNuclide BiopharmaradiopharmaceuticalPhase 1Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 39/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Positron-Emission Tomography(PET) cohort.
| Asset / Sponsor | Phase | Rating |
|---|
Same molecule, other indications
68ga-nota-sna002 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →